Antoine Lafont

11.0k total citations · 2 hit papers
101 papers, 6.9k citations indexed

About

Antoine Lafont is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antoine Lafont has authored 101 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 39 papers in Cardiology and Cardiovascular Medicine and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antoine Lafont's work include Coronary Interventions and Diagnostics (30 papers), Cardiac Imaging and Diagnostics (17 papers) and Cardiac Valve Diseases and Treatments (16 papers). Antoine Lafont is often cited by papers focused on Coronary Interventions and Diagnostics (30 papers), Cardiac Imaging and Diagnostics (17 papers) and Cardiac Valve Diseases and Treatments (16 papers). Antoine Lafont collaborates with scholars based in France, United States and Belgium. Antoine Lafont's co-authors include Albert Hagège, Aris Anastasakis, Philippe Charron, Burkert Pieske, Petros Nihoyannopoulos, Franco Cecchi, Jens Mogensen, Perry Elliott, Michael A. Borger and Stefano Nistri and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Antoine Lafont

99 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

2014 2.9k citations Perry Elliott, Aris Anastasakis et al. European Heart Journal profile →
Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study

2020 320 citations Éloi Marijon, Kumar Narayanan et al. profile →

Peers

Countries citing papers authored by Antoine Lafont

Since Specialization

Citations

This map shows the geographic impact of Antoine Lafont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoine Lafont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoine Lafont more than expected).

Fields of papers citing papers by Antoine Lafont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoine Lafont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoine Lafont. The network helps show where Antoine Lafont may publish in the future.

Co-authorship network of co-authors of Antoine Lafont

This figure shows the co-authorship network connecting the top 25 collaborators of Antoine Lafont. A scholar is included among the top collaborators of Antoine Lafont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoine Lafont. Antoine Lafont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early safety and mid-term clinical outcomes of technology transfer of transcatheter aortic valve implantation in patients with severe aortic valve stenosis in Vietnam: a single-center experience of 90 patients 2023 ·The Lancet Regional Health - Western Pacific ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Nguyen Lam Vuong, (unknown), (unknown), Ariel Finkelstein, Antoine Lafont	0
2	New European Regulation for Medical Devices 2020 ·European Heart Journal ·Nicolas Martelli, (unknown), Kumar Narayanan, Antoine Lafont, Éloi Marijon	2
3	The French emergency medical services after the Paris and Nice terrorist attacks: what have we learnt? 2017 ·The Lancet ·Pierre Carli, François Pons, J. Levraut, Bruno Millet, Jean-Pierre Tourtier, Bertrand Ludes, Antoine Lafont, Bruno Riou	57
4	Therapeutic Potential of Gingival Fibroblasts for Cutaneous Radiation Syndrome: Comparison to Bone Marrow-Mesenchymal Stem Cell Grafts 2015 ·Stem Cells and Development ·Christine Linard, (unknown), (unknown), Valérie Holler, Thomas Leclerc, Carine Strup-Perrot, Ludovic Couty, Bruno L’Homme, Marc Benderitter, Antoine Lafont, (unknown), Bernard Coulomb	22
5	ESC 2014 clinical practice guidelines on the diagnosis and management of hypertrophic cardiomyopathy 2015 ·Revista Española de Cardiología ·Perry Elliott, Aristides Anastasakis, Michael A. Borger, Martin Borggrefe, Franco Cecchi, Philippe Charron, Albert Hagège, Antoine Lafont, Giuseppe Limongelli, Heiko Mahrholdt, William J. McKenna, Jens Mogensen, Petros Nihoyannopoulos, Stefano Nistri, P.G. Pieper, Burkert Pieske, Claudio Rapezzi, Frans H. Rutten, Christoph Tillmanns, Hugh Watkins	1
6	2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy breakdown → 2014 ·European Heart Journal ·(unknown), Perry Elliott, Aris Anastasakis, Michael A. Borger, Martin Borggrefe, Franco Cecchi, Philippe Charron, Albert Hagège, Antoine Lafont, Giuseppe Limongelli, Heiko Mahrholdt, William J. McKenna, Jens Mogensen, Petros Nihoyannopoulos, Stefano Nistri, P.G. Pieper, Burkert Pieske, (unknown), (unknown), Christoph Tillmanns	2934
7	Inhibition of the Differentiation of Monocyte-Derived Dendritic Cells by Human Gingival Fibroblasts 2013 ·PLoS ONE ·Sylvie Séguier, Éric Tartour, Coralie L. Guérin, Ludovic Couty, Mathilde Lemitre, (unknown), (unknown), (unknown), Magali Terme, Cécile Badoual, Antoine Lafont, Bernard Coulomb	20
8	Multipotent Progenitor Cells in Gingival Connective Tissue 2010 ·Tissue Engineering Part A ·Benjamin Fournier, F. Ferré, Ludovic Couty, Jean‐Jacques Lataillade, (unknown), Adrien Naveau, Bernard Coulomb, Antoine Lafont, Bruno Gogly	128
9	Deployed Edwards Sapien prosthesis is always deformed 2010 ·Journal of Thoracic and Cardiovascular Surgery ·Rachid Zegdi, Didier Blanchard, Paul Achouh, Antoine Lafont, Alain Berrébi, Bernard Cholley, Jean‐Noël Fabiani	13
10	A.R.T.: concept of a bioresorbable stent without drug elution 2009 ·EuroIntervention ·Antoine Lafont, Éric Durand	20
11	Effect of Low Molecular Weight Fucoidan and Low Molecular Weight Heparin in a Rabbit Model of Arterial Thrombosis 2008 ·Journal of Vascular Research ·Éric Durand, Dominique Helley, Ayman Al Haj Zen, (unknown), Patrick Bruneval, Sylvia Colliec‐Jouault, Anne‐Marie Fischer, Antoine Lafont	41
12	Percutaneous coronary intervention-induced variations in systemic parameters of inflammation: relationship with the mode of stenting 2007 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Camille Brasselet, Roselyne Garnotel, (unknown), Fabien Vitry, J Elaerts, Antoine Lafont, Damien Metz, Philippe Gillery	5
13	Isolation of “Side Population” Progenitor Cells From Healthy Arteries of Adult Mice 2005 ·Arteriosclerosis Thrombosis and Vascular Biology ·Julie Sainz, Ayman Al Haj Zen, Giuseppina Caligiuri, Corinne Demerens, Dominique Urbain, Mathilde Lemitre, Antoine Lafont	128
14	Reduced immunoregulatory CD31+T cells in the blood of atherosclerotic mice with plaque thrombosis 2005 ·European Heart Journal ·Giuseppina Caligiuri, Émilie Groyer, Jamila Khallou‐Laschet, Ayman Al Haj Zen, Dominique Urbain, (unknown), Antonino Nicoletti, Antoine Lafont	4
15	The coronary sinus: A safe and effective route for percutaneous myoblast transplantation 2003 ·Journal of the American College of Cardiology ·Camille Brasselet, (unknown), Patrick Bruneval, Didier Heudes, Ketty Schwartz, Albert Hagège, Jean‐Thomas Vilquin, Emmanuel Messas, Michel Desnos, Antoine Lafont, Philippe Menasché	2
16	Thrombus Generation after Adenovirus-Mediated Gene Transfer into Atherosclerotic Arteries 1998 ·Human Gene Therapy ·Antoine Lafont, Éric Durand, F Vildé, (unknown), (unknown), (unknown), Massoud Mirshahi, Claude Guérot, Patricia Lemarchand	12
17	Vasomotor Dysfunction Early after Exposure of Normal Rabbit Arteries to an Adenoviral Vector 1997 ·Human Gene Therapy ·Antoine Lafont, Gervaise Loirand, Pierre Pacaud, F Vildé, Patricia Lemarchand, Denis Escande	37
18	Place du remodelage dans la resténose après angioplastie 1996 ·Sang thrombose vaisseaux ·Antoine Lafont, L Chapoutot, (unknown), (unknown), Yves Guérin, Michel Desnos, Claude Guérot	1
19	Prospects for gene therapy in cardiovascular disease 1996 ·European Heart Journal ·Antoine Lafont, (unknown), Patricia Lemarchand	14
20	Protection against ischemia during prolonged balloon inflation by distal coronary perfusion with use of an autoperfusion catheter or fluosol 1992 ·Journal of the American College of Cardiology ·Benjamin D. Robalino, Thomas H. Marwick, Antoine Lafont, (unknown), Patrick L. Whitlow	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact